Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00187
|
|||||
| Drug Name |
Prucalopride
|
|||||
| Synonyms |
0A09IUW5TP; 179474-81-8; 4-Amino-5-chloro-2,3-dihydro-N-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide; 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide; 4-Amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide; 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; C18H26ClN3O3; CHEMBL117287; Motegrity; Prucalopride [USAN:INN:BAN]; R 093877; R-093877; R0-93877; R093877; UNII-0A09IUW5TP
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic idiopathic constipation [ICD11: ME05.0] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H26ClN3O3
|
|||||
| Canonical SMILES |
COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl
|
|||||
| InChI |
InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)
|
|||||
| InChIKey |
ZPMNHBXQOOVQJL-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 179474-81-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 367.9 | Topological Polar Surface Area | 76.8 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10056110
, 103341576
, 104015490
, 111619007
, 124772073
, 126522466
, 126666797
, 126731460
, 129936276
, 134340386
, 135131495
, 135650861
, 135697691
, 136367812
, 137009981
, 142510835
, 143497674
, 14803834
, 152090515
, 152159696
, 152234885
, 162009741
, 162011596
, 162205091
, 164764612
, 170466188
, 170502890
, 174006285
, 174528011
, 175438062
, 179150084
, 185997006
, 188899543
, 196408592
, 198942073
, 198993142
, 210275056
, 210280694
, 223379010
, 223662148
, 226407081
, 249734221
, 251883665
, 251971243
, 252151346
, 36118680
, 50329889
, 57353981
, 85209596
, 96025885
|
|||||
| ChEBI ID |
CHEBI:135552
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Prucalopride was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Resolor, INN-prucalopride | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.